# ğŸ’Š Pharmaceutical Drug Sales Analysis

## ğŸ“„ Project Overview
This project involves the analysis of **pharmaceutical drug sales** using **SQL**, **Excel**, and **Power BI** to uncover sales trends, identify top- and bottom-performing products, and support business decisions through actionable insights.  
The interactive dashboard provides detailed visual insights into **sales revenue, quantity sold, operational performance metrics, product rankings, daily trends**, and **key performance indicators (KPIs)** for better understanding of drug performance over time.

---

## ğŸ¯ Objectives
- Visualize key metrics across revenue, quantity, orders, and product performance.  
- Analyze drug sales by revenue and quantity to determine high and low performing drug products.  
- Analyze daily sales trends for pattern discovery and forecasting.  
- Create an intuitive and interactive dashboard for stakeholder insights to enable data-driven decision making.

---

## ğŸ› ï¸ Tools & Technologies
- **Power BI:** For data modeling and visualization.  
- **Microsoft Excel:** For initial data cleaning, transformation, and calculated measures.  
- **SQL:** For data manipulation, sorting, and filtering.

---

## ğŸ“ Dataset
> **Note:** The dataset used in this project is not publicly available. However, a synthetic or sample version can be provided upon request.

**Fields Included:**
- Sales ID  
- Order Date  
- Drug Name  
- Price  
- Quantity  
- Total Revenue  

**Dataset Size:**
- 20,004 rows Ã— 6 columns  
- 100 unique drug products  
- 20K total orders  
- 110K total units ordered

---

## ğŸ“Š Exploratory Data Analysis
Key exploration steps included:
- Aggregating revenue and quantity by drug name.  
- Calculating average revenue per order.  
- Identifying top 10 best- and worst-selling drugs.  
- Analyzing daily sales volume and revenue patterns.

---

## ğŸ” Key Analysis and Visualizations

- **Total Revenue:** â‚¦12M  
- **Average Revenue per Order:** â‚¦622  
- **Total Quantity Ordered:** 110K  
- **Total Number of Drug Products:** 100  
- **Total Orders:** 20K  

### ğŸ”¹ Top 10 Revenue-Generating Drugs
*Azithromycin, Saxagliptin, Sertraline, Clonazepam, Clindamycin, Aripiprazole, Travoprost, Sitagliptin, Lactulose, Cetirizine* â€” with **Azithromycin** topping the chart at â‚¦231.11K.

### ğŸ”¹ Top 10 Drugs by Quantity Sold
*Escitalopram, Senna, Oxycodone, Trazodone, Polyethylene Glycol, Simvastatin, Clonazepam, Azithromycin, Enalapril, Saxagliptin* â€” with **Escitalopram** topping the chart with 1,345 units.

### ğŸ”¹ Bottom 10 Revenue-Generating Drugs
*Tramadol, Sildenafil, Lansoprazole, Amoxicillin, Levothyroxine, Topiramate, Warfarin, Lubiprostone, Dorzolamide, Bupropion* â€” with **Bupropion** being the least at â‚¦23K.

### ğŸ”¹ Bottom 10 Drugs by Quantity Sold
*Pioglitazone, Diclofenac, Fexofenadine, Risperidone, Lamotrigine, Dorzolamide, Linagliptin, Digoxin, Brimonidine, Bupropion* â€” with **Bupropion** being the least at 862 units.

### ğŸ”¹ Daily Sales Trends
- **Consistent Daily Revenue:** Sales remained steady across the 30-day period with peaks on days 11, 18, 21, and 24.  
- **Daily Ordered Quantity:** Quantity ordered daily remained quite  steady across the 30-day period with occasional peaks on days 1, 18 ,24, and 28.

---

## ğŸ” Key Insights

- **High-volume, low-revenue mismatch:**  
  Some drugs like *Escitalopram, Senna, Oxycodone, Trazodone, Polyethylene Glycol, Simvastatin,* and *Enalapril* had high sales volumes but generated relatively low revenue. This suggests a possible price-volume imbalance, pointing to opportunities for **pricing review** and **margin optimization**. But it is important to note that the review should be done with consideration of the actual cost price of the drugs since high-volume sales donâ€™t always translate to high revenue all the time.

- **Underperforming drug products:**  
Drugs like *dorzolamide* and *bupropion* performed poorly in both quantity and revenue, signaling possible *inefficiencies in product portfolio*, *tying up of inventory* and *potential effect on profitability*. This present an opportunity for *product re-evaluation*, *portfolio optimization* either through *promotional boosts* or *possible discontinuation*. 

- **Stable demand pattern:**  
Daily trends in revenue and quantity were steady, suggesting consistent and predictable consumer behavior, stable customer base and stable ordering pattern, a strength that is ideal for inventory planning and which can be further optimized. This flat and reliable sales trend indicates opportunities for predictive planning, mature market which is ripe for strategic interventions to grow margins rather than just volume.

 ---

## ğŸ’¡ Recommendations

### ğŸ’° Revenue Optimization
- Review pricing strategy for high-volume, low-revenue drugs to improve profit margins
- Consider bundling slow-moving drugs with top performers to increase turnover.

### ğŸ¯ Targeted Marketing
- Focus marketing efforts on top-performing drugs like **Azithromycin, Saxagliptin, Clonazepam, and Sertraline** to maximize ROI.
- Invest in promoting mid-tier drugs with untapped potential.  
- Boost visibility of low-performing drugs through promotions or targeted advertising to improve their sales and demand.

### ğŸª Inventory Adjustment & Management
- Align stock with demand trends to minimize holding costs and avoid shortage of high demand products.  
- Use historical trends for accurate **demand forecasting** and **restocking schedules**.  
- Avoid stockouts of top-selling drugs and improve **supply chain efficiency**.

### ğŸ” Underperforming Product Lifecycle Review
- Re-evaluate consistently underperforming drugs and consider strategic repositioning, promotion,  discontinuation, phasing out or repackaging to streamline operations and reduce waste.
- Investigate reasons for low performance of drugs like **Dorzolamide, Lubiprostone** Brimonidine, *Bupropion etc*, considering factors like demand, pricing, or shelf life.

---

**Dashboard Highlights:**
- KPI Cards for total revenue, average revenue, total quantity, total orders, and product count.  
- Line and Area charts for daily sales trends.  
- Column charts for top and bottom 10 drugs by revenue and quantity.  
- Dynamic filters by drug name and order date.

---

## ğŸ”„ Future Work
- Integrate **time-series forecasting** for future sales prediction.  
- Add **geographic segmentation** once location data becomes available.  
- Implement **drug classification** for category-level analysis.  
- Introduce **customer segmentation** if buyer data is included.

---

## ğŸ“¬ Contact

**Oluwatobiloba T.**  
ğŸ“§ [taiwooluwatobiloba2904@gmail.com](mailto:taiwooluwatobiloba2904@gmail.com)  
ğŸ”— [LinkedIn Profile](https://www.linkedin.com/in/oluwatobiloba-taiwo-dvm-b43b51366?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app)  
ğŸŒ [Portfolio Website](https://your-portfolio-link.com)

---
